All Stories

  1. N-of-1 trial designs in mental health: A qualitative study of their appropriateness, and barriers and facilitators to their use
  2. Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trial
  3. Walking the walk: a case study of partnering with patients in designing and delivering a patient and public involvement implementation plan
  4. Trial design and enrolment characteristics of LATA (long-acting treatment in adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting i...
  5. 2612P Exploring the influence of adjuvant immune checkpoint inhibition on health-related quality of life in renal cell carcinoma: A qualitative sub study within the RAMPART trial
  6. BREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART...
  7. Men's Preferences on Androgen Deprivation Therapy Options for Prostate Cancer Treatment
  8. Second-Line Antiretroviral Therapy for Children Living with HIV in Africa
  9. Master protocol for a series of cohort-based randomized controlled trials to test tools to communicate research results to study participants and others with relevant lived experience: the SPIN-CLEAR Trials
  10. Evaluation of person-centred outcome measures for use in clinical trials of tuberculosis therapeutics
  11. Sharing clinical trial results with participants: important, expected and possible
  12. Clinicians in low‐ and middle‐income settings need better access to point‐of‐care haemoglobin tests for identifying and managing children and pregnant women with severe anaemia
  13. Developing a knowledge transfer and exchange strategy for a clinical trials unit
  14. Population Pharmacokinetics of Dolutegravir in African Children: Results From the CHAPAS-4 Trial
  15. The SHOW RESPECT adaptable framework of considerations for planning how to share trial results with participants, based on qualitative findings from trial participants and site staff
  16. Hit it hard: qualitative patient perspectives on the optimisation of immune checkpoint inhibition
  17. The SHOW RESPECT adaptable framework of considerations for planning how to share trial results with participants, based on qualitative findings from trial participants and site staff
  18. Second-line tenofovir alafenamide for children with HIV in Africa
  19. CHAPAS-4 trial: second-line anchor drugs for children with HIV in Africa
  20. Voluntariness of consent in paediatric HIV clinical trials: a mixed-methods, cross-sectional study of participants in the CHAPAS-4 and ODYSSEY trials in Uganda
  21. The effectiveness of interventions to disseminate the results of non-commercial randomised clinical trials to healthcare professionals: a systematic review
  22. Use of point‐of‐care haemoglobin tests to diagnose childhood anaemia in low‐ and middle‐income countries: A systematic review
  23. PA-257 ‘Nothing about us without us’: multi-country adolescent patient-led recruitment information in the long-acting treatment in adolescents (LATA) trial – an animated video to compliment ‘traditional’ participant information
  24. Site staff perspectives on communicating trial results to participants: Cost and feasibility results from the Show RESPECT cluster randomised, factorial, mixed-methods trial
  25. Use of Point-of-care Haemoglobin Tests to Diagnose Childhood Anaemia in Low-and Middle-Income Countries: A Systematic Review
  26. Patients’ priorities around drug-resistant tuberculosis treatment: A multi-national qualitative study from Mongolia, South Africa and Georgia
  27. Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units
  28. Practical Guidance for Running Late-Phase Platform Protocols for Clinical Trials: Lessons From Experienced UK Clinical Trials Units
  29. Whole blood versus red cell concentrates for children with severe anaemia: a secondary analysis of the Transfusion and Treatment of African Children (TRACT) trial
  30. Testing approaches to sharing trial results with participants: The Show RESPECT cluster randomised, factorial, mixed methods trial
  31. Providing trial results to participants in phase III pragmatic effectiveness RCTs: a scoping review
  32. Transfusion management of severe anaemia in African children: a consensus algorithm
  33. “PROUD to have been involved”: an evaluation of participant and community involvement in the PROUD HIV prevention trial
  34. Effectiveness and acceptability of methods of communicating the results of clinical research to lay and professional audiences: protocol for a systematic review
  35. Predictive factors for HIV infection among men who have sex with men and who are seeking PrEP: a secondary analysis of the PROUD trial
  36. When participants get involved: reconsidering patient and public involvement in clinical trials at the MRC Clinical Trials Unit at UCL
  37. She knows that she will not come back: tracing patients and new thresholds of collective surveillance in PMTCT Option B+
  38. Meeting abstracts from the 4th International Clinical Trials Methodology Conference (ICTMC) and the 38th Annual Meeting of the Society for Clinical Trials
  39. Shifting human resources for health in the context of ART provision: qualitative and quantitative findings from the Lablite baseline study
  40. Erratum to: ‘Models and impact of patient and public involvement in studies carried out by the Medical Research Council Clinical Trials Unit at University College London: findings from ten case studies’
  41. Estimating the Impact of Randomised Control Trial Results on Clinical Practice: Results from a Survey and Modelling Study of Androgen Deprivation Therapy plus Radiotherapy for Locally Advanced Prostate Cancer
  42. Models and impact of patient and public involvement in studies carried out by the Medical Research Council Clinical Trials Unit at University College London: findings from ten case studies
  43. Sharing data from clinical trials: the rationale for a controlled access approach
  44. The Lablite project: A cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe
  45. Authors' reply to Southall
  46. WHO guidelines on fluid resuscitation in children: missing the FEAST data
  47. Do accurate HIV and antiretroviral therapy knowledge, and previous testing experiences increase the uptake of HIV voluntary counselling and testing? Results from a cohort study in rural Tanzania
  48. HIV treatment and care systems
  49. Evidence for Action on HIV treatment and care systems in low and middle-income countries
  50. Designing and implementing a communications strategy: lessons learnt from HIV and Sexual and Reproductive Health Research Programme Consortia
  51. Improving communication of research findings: identifying the sources of information most important to national disease control officers in low- and middle-income countries